ZJU-11747-26811
4 vaccinations
2 coded responses
50 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 460 / IN
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
Z2K-26140-43388
Child or adolescent in my care · Male · 2022-07-09
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-11
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-03
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had Covid at the end of January/early FebruaryMedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-06
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-09-19
Dose 4 — ModernaCo-administered: Flu
- 2022-09-19
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
-
2022-10-31
Survey response — day 42, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairFree text: I have a cold. Covid test was negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-19
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-19 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-04 | Successful 2022-04-06 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 6 months, dose 3
Symptoms: I had Covid at the end of January/early February
Release 12 — day 42, dose 4
Symptoms: I have a cold. Covid test was negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release